Mouse model reveals new insights about amyotrophic lateral sclerosis

ALS is a very severe neurodegenerative disease in which nerve cells in the spinal cord controlling muscles and movement slowly die. There is no effective treatment and the average life expectancy after being diagnosed with ALS is usually short. Because of this, new knowledge about the disease is urgently needed.

Now, researchers from the University of Copenhagen have gained new insights about ALS, by investigating the early development of the disease in a mouse model.

We have found that networks of nerve cells in the spinal cord called inhibitory interneurons lose connection to motor neurons, the nerve cells that directly control muscle contraction. We do not yet know if these changes cause the disease. But the loss of the inhibitory signal could explain why the motor neurons end up dying in ALS",

Ilary Allodi, Study Ffirst and Co-Corresponding Author and ssistant Professor, Department of Neuroscience, University of Copenhagen

A lot of ALS research have focused on the motor neurons themselves, but the research group at the University of Copenhagen had a different approach.

"It is only natural that motor neurons have received major attention. They control our muscles, which is the challenge for ALS patients. Here, we wanted to investigate the circuit of interneurons in the spinal cord because they determine the activity of motor neurons. Since we found that there is a loss of connections between inhibitory interneurons and motor neurons that happens before the motor neuron death, we think that this loss could be a possible explanation for why the motor neurons ends up dying in ALS patients", says Ole Kiehn, senior, co-corresponding author and Professor at the Department of Neuroscience.

Fast-twitch first

In ALS patients, the degeneration typically starts with what is called the fast-twitch motor neurons and then goes on to other motor neurons. This means that certain muscles and bodily functions are affected before others. Normally, patients lose coordination and speed in movement before more basic functions such as breathing. This is mirrored in the new findings, according to the researchers.

"In our mouse model, we show that the loss of connection happens to fast motor neurons first and then slow motor neurons later on involve a particular type of inhibitory neurons, the so called V1 interneurons", says Roser Montañana-Rosell, who is PhD student and shared first author on the study.

"The V1 interneuron connectivity loss is paralleled by the development of a specific locomotor deficit in the pre-symptomatic phase with lower speed and changes in limb coordination in the ALS mice that is dependent on V1 interneuron connections to motor neuron", says Ole Kiehn.

Expanding the window of opportunity

The researchers underline that the mechanisms should be investigated in human patients as well. However, they do not have any reason to believe that the same or similar biological mechanisms are not at play in humans.

Given the new understanding of the disease, Ilary Allodi hopes further research into the signaling process could reveal how to repair the nerve cell connection loss in ALS.

"We definitely hope that our findings can contribute with a new way of thinking about ALS development. With a distinct focus on interneurons, we might be able, in future experiments, to increase the signaling processes from the interneurons to the motor neurons and prevent or delay the motor neuron degeneration from an early stage," ends Ilary Allodi.

Read the entire study in Nature Communications: "Locomotor deficits in a mouse model of ALS are paralleled by loss of V1-interneuron connections onto fast motor neurons"

Source:
Journal reference:

Allodi, I., et al. (2021) Locomotor deficits in a mouse model of ALS are paralleled by loss of V1-interneuron connections onto fast motor neurons. Nature Communications. doi.org/10.1038/s41467-021-23224-7.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New Study Links Cannabis Use to DNA Methylation Changes in Mental Health Pathways